CIRCULATING MIR-625-3P: A POTENTIAL BIOMARKER FOR MALIGNANT PLEURAL MESOTHELIOMA

被引：0
|
作者：
Kirschner, M. B. [1 ]
Cheng, Y. Y. [1 ]
Badrian, B. [2 ,3 ]
Kao, S. C. [1 ,4 ]
Creaney, J. [5 ,6 ]
Edelman, J. J. B. [7 ,8 ]
Harvie, R. [9 ,10 ]
Armstrong, N. J. [11 ,12 ]
Vallely, M. P. [7 ,8 ]
Musk, A. W. [5 ,6 ,13 ]
Robinson, B. W. S. [5 ,6 ]
McCaughan, B. C. [7 ,8 ]
Pavlakis, N. [9 ,10 ]
Klebe, S. [14 ]
Mutsaers, S. E. [2 ,3 ]
van Zandwijk, N. [1 ]
Reid, G. [1 ]
机构：
[1] Univ Sydney, Asbestos Dis Res Inst, Sydney, NSW 2006, Australia
[2] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Lung Inst Western Australia, Nedlands, WA 6009, Australia
[3] Univ Western Australia, Pathwest Labs Med, Nedlands, WA 6009, Australia
[4] Concord Hosp, Dept Med Oncol, Sydney, NSW, Australia
[5] Univ Western Australia, Sch Med & Pharmacol, Natl Res Ctr Asbestos Related Dis, Nedlands, WA 6009, Australia
[6] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia
[7] Univ Sydney, Royal Prince Alfred Hosp, Cardiothorac Surg Unit, Baird Inst, Sydney, NSW 2006, Australia
[8] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia
[9] Univ Sydney, Royal N Shore Hosp, Bill Walsh Canc Res Labs, Kolling Inst Med Res, Sydney, NSW 2006, Australia
[10] Univ Sydney, Royal N Shore Hosp, Dept Med Oncol, Sydney, NSW 2006, Australia
[11] Univ New S Wales, Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2052, Australia
[12] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia
[13] Univ Western Australia, Dept Populat Hlth, Nedlands, WA 6009, Australia
[14] Flinders Med Ctr, Dept Anat Pathol, Adelaide, SA, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S174 / S174
页数：1
相关论文
共 50 条
  • [1] Increased Circulating miR-625-3p A Potential Biomarker for Patients With Malignant Pleural Mesothelioma
    Kirschner, Michaela B.
    Cheng, Yuen Yee
    Badrian, Bahareh
    Kao, Steven C.
    Creaney, Jenette
    Edelman, J. James B.
    Armstrong, Nicola J.
    Vallely, Michael P.
    Musk, Arthur W.
    Robinson, Bruce W. S.
    McCaughan, Brian C.
    Klebe, Sonja
    Mutsaers, Steven E.
    van Zandwijk, Nico
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1184 - 1191
  • [2] Extracellular Vesicle Enriched miR-625-3p Is Associated with Survival of Malignant Mesothelioma Patients
    Goricar, Katja
    Holcar, Marija
    Mavec, Nina
    Kovac, Viljem
    Lenassi, Metka
    Dolzan, Vita
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (10):
  • [3] Evaluation of miR-21 as a novel circulating biomarker in malignant pleural mesothelioma
    Laszlo, Viktoria
    Dong, Yawen
    Hoda, Mir Alireza
    Klikovits, Thomas
    Lang, Elisabeth
    Benazzo, Alberto
    Berger, Walter
    Klepetko, Walter
    Grusch, Michael
    Dome, Balazs
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (19-20) : 757 - 757
  • [4] Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma
    Weber, Daniel G.
    Gawrych, Katarzyna
    Casjens, Swaantje
    Brik, Alexander
    Lehnert, Martin
    Taeger, Dirk
    Pesch, Beate
    Kollmeier, Jens
    Bauer, Torsten T.
    Johnen, Georg
    Brning, Thomas
    DISEASE MARKERS, 2017, 2017
  • [5] miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma
    Williams, Marissa
    Kirschner, Michaela B.
    Cheng, Yuen Yee
    Hanh, Jacky
    Weiss, Jocelyn
    Mugridge, Nancy
    Wright, Casey M.
    Linton, Anthony
    Kao, Steven C.
    Edelman, J. James B.
    Vallely, Michael P.
    McCaughan, Brian C.
    Cooper, Wendy
    Klebe, Sonja
    Lin, Ruby C. Y.
    Brahmbhatt, Himanshu
    MacDiarmid, Jennifer
    van Zandwijk, Nico
    Reid, Glen
    ONCOTARGET, 2015, 6 (27) : 23480 - 23495
  • [6] miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery
    Kresoja-Rakic, Jelena
    Szpechcinski, Adam
    Kirschner, Michaela B.
    Ronner, Manuel
    Minatel, Brenda
    Martinez, Victor D.
    Lam, Wan L.
    Weder, Walter
    Stahel, Rolf
    Fruh, Martin
    Cerciello, Ferdinando
    Felley-Bosco, Emanuela
    NON-CODING RNA, 2019, 5 (02)
  • [7] Fibulin-3: A Potential Prognostic Biomarker in Malignant Pleural Mesothelioma?
    Kirschner, Michaela B.
    Pulford, Emily
    Hoda, Mir A.
    Rozsas, Anita
    Griggs, Kim
    Edelman, J. James B.
    Kao, Steven
    Hyland, Rebecca
    Dong, Yawen
    Laszlo, Viktoria
    Klikovits, Thomas
    Jakopovic, Marko
    Vallely, Michael
    Grusch, Michael
    Hegedus, Balazs
    Dome, Balazs
    Klepetko, Walter
    Van Zandwijk, Nico
    Klebe, Sonja
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S747 - S747
  • [8] Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
    B Ghanim
    M A Hoda
    T Klikovits
    M-P Winter
    A Alimohammadi
    M Grusch
    B Dome
    M Arns
    P Schenk
    M Jakopovic
    M Samarzija
    L Brcic
    M Filipits
    V Laszlo
    W Klepetko
    W Berger
    B Hegedus
    British Journal of Cancer, 2014, 110 : 984 - 990
  • [9] Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
    Ghanim, B.
    Hoda, M. A.
    Klikovits, T.
    Winter, M-P
    Alimohammadi, A.
    Grusch, M.
    Dome, B.
    Arns, M.
    Schenk, P.
    Jakopovic, M.
    Samarzija, M.
    Brcic, L.
    Filipits, M.
    Laszlo, V.
    Klepetko, W.
    Berger, W.
    Hegedus, B.
    BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 984 - 990
  • [10] Putting a brake on stress signaling: miR-625-3p as a biomarker for choice of therapy in colorectal cancer
    Lyskjaer, Iben
    Rasmussen, Mads H.
    Andersen, Claus L.
    EPIGENOMICS, 2016, 8 (11) : 1449 - 1452
12345